Advertisement

Sleep Breathing Disorders in Heart Failure

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Cardiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Young T.
        • Peppard P.E.
        • Gottlieb D.J.
        Epidemiology of obstructive sleep apnea: a population health perspective.
        Am J Respir Crit Care Med. 2002; 165: 1217-1239
        • Franklin K.A.
        • Lindberg E.
        Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea.
        J Thorac Dis. 2015; 7: 1311-1322
        • Haruki N.
        • Floras J.S.
        Sleep-disordered breathing in heart failure- a therapeutic dilemma.
        Circ J. 2017; 81: 903-912
        • Oldenburg O.
        • Lamp B.
        • Faber L.
        • et al.
        Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients.
        Eur J Heart Fail. 2007; 9: 251-257
        • Dempsey J.A.
        • Veasey S.C.
        • Morgan B.J.
        • et al.
        Pathophysiology of sleep apnea.
        Physiol Rev. 2010; 90: 47-112
        • Jordan A.S.
        • McSharry D.G.
        • Malhotra A.
        Adult obstructive sleep apnoea.
        Lancet. 2014; 383: 736-747
        • Javaheri S.
        • Dempsey J.A.
        Central sleep apnea.
        Compr Physiol. 2013; 3: 141-163
        • Lyons O.D.
        • Bradley T.D.
        Heart failure and sleep apnea.
        Can J Cardiol. 2015; 31: 898-908
        • Perger E.
        • Inami T.
        • Lyons O.D.
        • et al.
        Distinct patterns of hyperpnea during Cheyne-Stokes respiration: implication for cardiac function in patients with heart failure.
        J Clin Sleep Med. 2017; 13: 1235-1241
        • Vazir A.
        • Hastings P.C.
        • Dayer M.
        • et al.
        A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction.
        Eur J Heart Fail. 2007; 9: 243-250
        • Arzt M.
        • Harth M.
        • Luchner A.
        • et al.
        Enhanced ventilatory response to exercise in patients with chronic heart failure and central sleep apnea.
        Circulation. 2003; 107: 1998-2003
        • Naughton M.T.
        Cheyne-Stokes respiration: friend or foe?.
        Thorax. 2012; 67: 357-360
        • Sands S.A.
        • Owens R.L.
        Congestive heart failure and central sleep apnea.
        Crit Care Clin. 2015; 31: 473-495
        • Peppard P.E.
        • Young T.
        • Barnet J.H.
        • et al.
        Increased prevalence of sleep-disordered breathing in adults.
        Am J Epidemiol. 2013; 177: 1006-1014
        • Khayat R.
        • Abraham W.
        • Patt B.
        • et al.
        Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure.
        J Card Fail. 2012; 18: 534-540
        • Wang H.
        • Parker J.D.
        • Newton G.E.
        • et al.
        Influence of obstructive sleep apnea on mortality in patients with heart failure.
        J Am Coll Cardiol. 2007; 49: 1625-1631
        • Bitter T.
        • Westerheide N.
        • Prinz C.
        • et al.
        Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure.
        Eur Heart J. 2011; 32: 61-74
        • Yumino D.
        • Wang H.
        • Floras J.S.
        • et al.
        Relationship between sleep apnoea and mortality in patients with ischaemic heart failure.
        Heart. 2009; 95: 819-824
        • Yumino D.
        • Kasai T.
        • Kimmerly D.
        • et al.
        Differing effects of obstructive and central sleep apneas on stroke volume in patients with heart failure.
        Am J Respir Crit Care Med. 2013; 187: 433-438
        • Bradley T.D.
        • Tkacova R.
        • Hall M.J.
        • et al.
        Augmented sympathetic neural response to simulated obstructive apnoea in human heart failure.
        Clin Sci (Lond). 2003; 104: 231-238
        • Jouett N.P.
        • Watenpaugh D.E.
        • Dunlap M.E.
        • et al.
        Interactive effects of hypoxia, hypercapnia and lung volume on sympathetic nerve activity in humans.
        Exp Physiol. 2015; 100: 1018-1029
        • Floras J.S.
        • Ponikowski P.
        The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction.
        Eur Heart J. 2015; 36: 1974-1982b
        • Malone S.
        • Liu P.P.
        • Holloway R.
        • et al.
        Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure.
        Lancet. 1991; 338: 1480-1484
        • Kasai T.
        • Narui K.
        • Dohi T.
        • et al.
        Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure.
        Chest. 2008; 133: 690-696
        • Javaheri S.
        A mechanism of central sleep apnea in patients with heart failure.
        N Engl J Med. 1999; 341: 949-954
        • Hall M.J.
        • Xie A.
        • Rutherford R.
        • et al.
        Cycle length of periodic breathing in patients with and without heart failure.
        Am J Respir Crit Care Med. 1996; 154: 376-381
        • Sin D.D.
        • Fitzgerald F.
        • Parker J.D.
        • et al.
        Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure.
        Am J Respir Crit Care Med. 1999; 160: 1101-1106
        • Naghshin J.
        • Rodriguez R.H.
        • Davis E.M.
        • et al.
        Chronic intermittent hypoxia exposure improves left ventricular contractility in transgenic mice with heart failure.
        J Appl Physiol (1985). 2012; 113: 791-798
        • Pinna G.D.
        • Robbi E.
        • Pizza F.
        • et al.
        Can cardiorespiratory polygraphy replace portable polysomnography in the assessment of sleep-disordered breathing in heart failure patients?.
        Sleep Breath. 2014; 18: 475-482
        • Vazir A.
        • Sundaram V.
        Management of sleep apnea in heart failure.
        Heart Fail Clin. 2018; 14: 635-642
        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • et al.
        2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
        J Card Fail. 2017; 23: 628-651
        • Gwag H.B.
        • Park Y.
        • Lee S.S.
        • et al.
        Rationale, design, and endpoints of the 'DEvice-Detected CArdiac Tachyarrhythmic Events and Sleep-disordered Breathing (DEDiCATES)' study: Prospective multicenter observational study of device-detected tachyarrhythmia and sleep-disordered breathing.
        Int J Cardiol. 2019; 280: 69-73
        • Oldenburg O.
        • Faber L.
        • Vogt J.
        • et al.
        Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing.
        Eur J Heart Fail. 2007; 9: 820-826
        • Engleman H.M.
        • Martin S.E.
        • Deary I.J.
        • et al.
        Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome.
        Lancet. 1994; 343: 572-575
        • Kaneko Y.
        • Floras J.S.
        • Usui K.
        • et al.
        Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea.
        N Engl J Med. 2003; 348: 1233-1241
        • Mansfield D.R.
        • Gollogly N.C.
        • Kaye D.M.
        • et al.
        Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure.
        Am J Respir Crit Care Med. 2004; 169: 361-366
        • Egea C.J.
        • Aizpuru F.
        • Pinto J.A.
        • et al.
        Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study.
        Sleep Med. 2008; 9: 660-666
        • Javaheri S.
        • Caref E.B.
        • Chen E.
        • et al.
        Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure.
        Am J Respir Crit Care Med. 2011; 183: 539-546
        • McEvoy R.D.
        • Antic N.A.
        • Heeley E.
        • et al.
        CPAP for prevention of cardiovascular events in obstructive sleep apnea.
        N Engl J Med. 2016; 375: 919-931
        • Qiu Z.H.
        • Luo Y.M.
        • McEvoy R.D.
        The Sleep Apnea Cardiovascular Endpoints (SAVE) study: implications for health services and sleep research in China and elsewhere.
        J Thorac Dis. 2017; 9: 2217-2220
        • Bradley T.D.
        • Logan A.G.
        • Kimoff R.J.
        • et al.
        Continuous positive airway pressure for central sleep apnea and heart failure.
        N Engl J Med. 2005; 353: 2025-2033
        • Arzt M.
        • Floras J.S.
        • Logan A.G.
        • et al.
        Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP).
        Circulation. 2007; 115: 3173-3180
        • Tkacova R.
        • Liu P.P.
        • Naughton M.T.
        • et al.
        Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure.
        J Am Coll Cardiol. 1997; 30: 739-745
        • Naughton M.T.
        • Benard D.C.
        • Liu P.P.
        • et al.
        Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea.
        Am J Respir Crit Care Med. 1995; 152: 473-479
        • Naughton M.T.
        • Liu P.P.
        • Bernard D.C.
        • et al.
        Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure.
        Am J Respir Crit Care Med. 1995; 151: 92-97
        • Cowie M.R.
        • Woehrle H.
        • Wegscheider K.
        • et al.
        Adaptive servo-ventilation for central sleep apnea in systolic heart failure.
        N Engl J Med. 2015; 373: 1095-1105
        • Bradley T.D.
        • Holloway R.M.
        • McLaughlin P.R.
        • et al.
        Cardiac output response to continuous positive airway pressure in congestive heart failure.
        Am Rev Respir Dis. 1992; 145: 377-382
        • Xie J.
        • Covassin N.
        • Chahal A.A.
        • et al.
        Effect of adaptive servo-ventilation on periodic limb movements in sleep in patients with heart failure.
        Am J Cardiol. 2019; 123: 632-637
        • Lyons O.D.
        • Floras J.S.
        • Logan A.G.
        • et al.
        Design of the effect of adaptive servo-ventilation on survival and cardiovascular hospital admissions in patients with heart failure and sleep apnoea: the ADVENT-HF trial.
        Eur J Heart Fail. 2017; 19: 579-587
        • Perger E.
        • Lyons O.D.
        • Inami T.
        • et al.
        Predictors of one year compliance with adaptive servo-ventilation in patients with heart failure and sleep- disordered breathing: preliminary data from the ADVENT-HF trial.
        Eur Respir J. 2019; 53 ([pii:1801626])
        • Jagielski D.
        • Ponikowski P.
        • Augostini R.
        • et al.
        Transvenous stimulation of the phrenic nerve for the treatment of central sleep apnoea: 12 months' experience with the remede((R)) System.
        Eur J Heart Fail. 2016; 18: 1386-1393
        • Costanzo M.R.
        • Ponikowski P.
        • Coats A.
        • et al.
        Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure.
        Eur J Heart Fail. 2018; 20: 1746-1754
        • Nakao Y.M.
        • Ueshima K.
        • Yasuno S.
        • et al.
        Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study.
        Heart Vessels. 2016; 31: 165-172
        • Bordier P.
        • Lataste A.
        • Hofmann P.
        • et al.
        Nocturnal oxygen therapy in patients with chronic heart failure and sleep apnea: a systematic review.
        Sleep Med. 2016; 17: 149-157
        • Javaheri S.
        • Sands S.A.
        • Edwards B.A.
        Acetazolamide attenuates Hunter-Cheyne-Stokes breathing but augments the hypercapnic ventilatory response in patients with heart failure.
        Ann Am Thorac Soc. 2014; 11: 80-86